A U.S. post-approval study of the PROMUS Element™ plus everolimus-eluting platinum chromium coronary stent system,
Role: PI,
Boston Scientific Corp.,
(03/2018 - 03/2019)
Status: Completed
OMEGA: A prospective, multicenter single-arm trial to assess the OMEGA coronary stent system for the treatment of a single de novo coronary artery lesion,
Role: PI,
Boston Scientific Corp.,
(06/2013 - 06/2014)
Status: Completed
The TRANSLATE-ACS study: Treatment with ADP receptor inhibitors: Longitudinal assessment of treatment patterns and events after acute coronary syndrome,
Role: PI,
Eli Lilly & Co.,
(05/2013 - 05/2014)
Status: Completed
Evaluation of clinical impact of non-invasive hemodynamic monitoring to optimize preventive care of heart failure patients,
Role: Investigator,
LLU Dept. of Anesthesiology,
(09/2020 - 09/2021)
Status: Completed
National cardiogenic shock initiative,
Role: Investigator,
LLU Dept. of Cardiology,
(07/2020 - 07/2021)
Status: Completed
A Retrospective Analysis and Review of Patients Undergoing Impella, a Temporary Left Ventricular Support Device, Implantation for Complex Coronary Intervention or Cardiogenic Shock,
Role: Investigator,
LLU Dept. of Medicine,
(04/2020)
Status: Approved
Cardiovascular Disease in SARS-Coronavirus 2 (SARS-CoV-2),
Role: Investigator,
LLU Dept. of Medicine,
(04/2020)
Status: Approved
Morbidity and mortality associated with the current practice of inotrope administration in CCU,
Role: Investigator,
LLU Dept. of Medicine,
(02/2019)
Status: Approved
Non-Profit Organization
Cardiovascular inflammation reduction trial (CIRT): a randomized, double-blind, placebo-controlled, event-driven trial of weekly low-dose Methotrexate(LDM) in the prevention of cardiovascular events among stable coronary artery disease patients with type 2 diabetes or metabolic syndrome,
Role: Investigator,
Brigham & Women's Hospital,
(08/2017 - 08/2018)
Status: Completed